SCHEMBL17844156

SCHEMBL17844156

COCCn1sc(-c2ccccc2)c(NC2CCC(O)CC2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.36
CYP2C9 P11712 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PDE4B Q07343 2/20 0.34
PDE7A Q13946 1/20 0.34
KAT2B Q92831 1/20 0.34
FYN P06241 2/20 0.34
MAPK14 Q16539 1/20 0.34
PDE5A O76074 2/20 0.33
PDE6A P16499 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK8 P45983 1/20 0.33
PDE4D Q08499 1/20 0.33
PDE11A Q9HCR9 1/20 0.33
BTK Q06187 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17844168 0.87 MAPK1 (0.37) ADORA2BPDE4BPDE7AMAPK14ALDH1A1
SCHEMBL17844251 0.86 FAAH (0.39) ADORA2BPDE4BPDE7AALDH1A1
SCHEMBL5199815 0.85 ADORA2B (0.35) ADORA2BCYP2C9SMN1; SMN2KAT2BALDH1A1
SCHEMBL17844225 0.77 MAPK10 (0.42) ADORA2BPDE4BPDE7AFYNL3MBTL1
SCHEMBL17844241 0.77 MAPK10 (0.42) ADORA2BPDE4BPDE7AFYNL3MBTL1
SCHEMBL17844144 0.74 FAAH (0.40) ADORA2BCYP2C9SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL2004915 0.70 BRD4 (0.37) CYP2C9SMN1; SMN2MAPK14PDE5APDE6A
SCHEMBL17844132 0.69 FAAH (0.39) ADORA2BKAT2BALDH1A1CYP3A4HSD17B10
SCHEMBL3503724 0.68 MAPT (0.45) CYP2C9SMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL5186704 0.67 FAAH (0.38) ADORA2BSMN1; SMN2PDE4BPDE7APDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016100619-A2 TREATMENT AND DIAGNOSIS OF CANCER RGENIX, INC. (US) 2016-06-23 WO disclosed